A prospective phase II study of cetuximab in combination with XELOX (capecitabine and oxaliplatin) in patients with metastatic and/or recurrent advanced gastric cancer
2009 ◽
Vol 29
(2)
◽
pp. 366-373
◽
Keyword(s):
Phase Ii
◽